# US 2019/0240234 A1 · Pharmaceutical composition for treatment of increased intraocular pressure

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0240234 A1
- Document ID: US20190240234A1
- Status: Published application
- Kind: A1
- Application number: 16/387,233
- Filed: 2019-04-17
- Published: 2019-08-08
- Earliest claimed: 2010-03-17
- Assignees: Novaliq GmbH
- Inventors: Bastian THEISINGER; Sonja THEISINGER; Bernhard GÜNTHER
- Web page: https://patentgrep.com/patent/US20190240234A1

## CPC

- A61K 31/5575: having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 47/06: Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61P 27/02: Ophthalmic agents
- A61P 27/06: Antiglaucoma agents or miotics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention provides novel pharmaceutical compositions based on semifluorinated alkanes which are useful as carriers for a broad range of active ingredients. Preferred active ingredients include poorly water-soluble prostaglandin analogues. The invention further provides kits comprising such compositions.

## Claims

### Claim at position 1

1-15. (canceled)

### Claim 16

A pharmaceutical composition comprising:
(a) a therapeutically effective amount of a poorly water-soluble prostaglandin analogue selected from the group consisting of latanoprost, bimatoprost, tafluprost, travoprost and unoprostone, and
(b) a liquid vehicle comprising a semifluorinated alkane selected from F4H5, F4H6, F6H6 and F6H8;
wherein the composition is substantially free of water and free of a preservative, and wherein the composition is formulated as a solution, emulsion or suspension.

### Claim 17 (depends on 16)

The composition of claim 16, wherein the active ingredient is latanoprost.

### Claim 18 (depends on 17)

The composition of claim 17, wherein the concentration of latanoprost is from about 0.001 wt.-% to about 0.01 wt.-%.

### Claim 19 (depends on 16)

The composition of claim 16, wherein the composition is formulated as a solution.

### Claim 20 (depends on 16)

The composition of claim 16, further comprising an organic cosolvent.

### Claim 21 (depends on 20)

The composition of claim 20, comprising ethanol at a concentration of about 1.5 wt.-% or less, or of about 1.0 wt.-% or less.

### Claim 22 (depends on 16)

The composition of claim 16, wherein the semifluorinated alkane is F4H5.

### Claim 23 (depends on 22)

The composition of claim 22, wherein the composition is formulated as a solution.

### Claim 24 (depends on 23)

The composition of claim 23, further comprising an organic co-solvent.

### Claim 25 (depends on 24)

The composition of claim 24, wherein the organic co-solvent is ethanol at a concentration of about 1.5 wt.-% or less.

### Claim 26 (depends on 22)

The composition of claim 22, wherein the active ingredient is latanoprost

### Claim 27 (depends on 26)

The composition of claim 26, wherein the concentration of latanoprost is from about 0.001 wt.-% to about 0.01 wt.-%.

### Claim 28 (depends on 27)

The composition of claim 27, wherein the composition is formulated as a solution.

### Claim 29 (depends on 28)

The composition of claim 28, further comprising an organic co-solvent.

### Claim 30 (depends on 29)

The composition of claim 29, wherein the organic co-solvent is ethanol at a concentration of about 1.5 wt.-% or less.

### Claim 31 (depends on 16)

A pharmaceutical kit comprising the composition of claim 16 and a container holding the composition, wherein the container has a dispensing means.

### Claim 32 (depends on 26)

A pharmaceutical kit comprising the composition of claim 26 and a container holding the composition, wherein the container has a dispensing means.
